Skip to main content

Table 1 Clinical characteristics of inflammatory bowel disease patients with or without sleep disturbances

From: Sleep disturbances in Japanese patients with inflammatory bowel disease and their impact on disease flare

 

Sleep disturbances (−)

Sleep disturbances (+)

p value

(N = 76)

(N = 60)

Age (years)

43.8 ± 15.3

41.5 ± 20.6

0.48

Male sex (%)

54.3

56.7

0.61

Body mass index (kg/m2)

21.6 ± 2.7

21.2 ± 3.6

0.57

Alcohol drinking (%)

26.3

31.7

0.57

Smoking (%)

6.6

16.7

0.10

Caffeine intake (%)

53.9

41.7

0.17

IBD type

 UC

68.4

60.0

0.37

 CD

31.6

40.0

 

Disease duration (years)

11.7 ± 8.5

10.9 ± 8.8

0.57

Active disease (%)

14.5

18.3

0.64

HBI

1.08 ± 2.33

1.68 ± 2.90

0.42

pMayo score

1.19 ± 1.66

1.74 ± 1.96

0.18

Prior IBD surgery (%)

47.4

53.3

0.61

Medication used

 Steroids (%)

2.6

5.0

0.65

 5-aminosalicylates (%)

78.9

78.3

1.00

 Immunomodulators (%)

28.9

13.3

0.04

 Anti-TNF biologics (%)

27.6

23.3

0.69

 Sleep medications (%)

2.6

25.0

<0.01

  1. Data are expressed as mean ± SD, or frequency. IBD inflammatory bowel disease, UC ulcerative colitis, CD Crohn’s disease, HBI Harvey-Bradshaw Index, pMayo partial Mayo score, TNF tumor necrosis factor